See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2020_Corvus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 79,344,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,462,000 |
| 3 | remainder_Assets | 2,840,000 |
| 4 | LiabilitiesCurrent | 10,225,000 |
| 5 | LiabilitiesNoncurrent | 2,310,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,994,513 |
| 9 | ResearchAndDevelopmentExpense | 37,704,649 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,163,331 |
| 13 | remainder_ComprehensiveNetIncome | 341,664 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 83,646,000 |
| 1 | Liabilities | 12,535,000 |
| 2 | Expenses | 48,699,162 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 71,111,000 |
| 5 | NetIncome | -46,535,831 |
| 6 | ComprehensiveNetIncome | -46,364,999 |
| 7 | BaseVar | 73,692,578 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.26 |
| 9 | EconomicCapitalRatio | 3.20 |
Edgar->Model Mapping
Feature Distribution
Change over Time
